Next report date
Report period
Q1 2024
EPS estimate
−0.06CHF
Revenue estimate
194.48 MCHF
−77.98 MCHF
726.16 MCHF
146.24 M
About EVOTEC SE INH O.N.
Sector
CEO
Mario Eugenio Cosimino Polywka
Headquarters
Hamburg
Website
Employees (FY)
5 K
Founded
1998
ISIN
DE0005664809
FIGI
BBG006TLPSX3
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties. The EVT Innovate develops drug discovery projects, assets and platforms, both internally or through academic collaborations. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, and Charles Weissmann on December 8, 1993 and is headquartered in Hamburg, Germany.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of EVT is 9.938 CHF — it has increased by 5.98% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange EVOTEC SE stocks are traded under the ticker EVT.
EVOTEC SE is going to release the next earnings report on May 22, 2024. Keep track of upcoming events with our Earnings Calendar.
EVT stock is 5.89% volatile and has beta coefficient of 0.92. Check out the list of the most volatile stocks — is EVOTEC SE there?
EVT earnings for the last quarter are −0.21 CHF per share, whereas the estimation was −0.06 CHF resulting in a −266.67% surprise. The estimated earnings for the next quarter are 0.01 CHF per share. See more details about EVOTEC SE earnings.
EVOTEC SE revenue for the last quarter amounts to 189.95 M CHF despite the estimated figure of 170.56 M CHF. In the next quarter revenue is expected to reach 192.38 M CHF.
Yes, you can track EVOTEC SE financials in yearly and quarterly reports right on TradingView.
EVT stock has fallen by 23.26% compared to the previous week, the month change is a 21.67% fall, over the last year EVOTEC SE has showed a 46.56% decrease.
EVT net income for the last quarter is −14.99 M CHF, while the quarter before that showed −37.70 M CHF of net income which accounts for 60.24% change. Track more EVOTEC SE financial stats to get the full picture.
Today EVOTEC SE has the market capitalization of 1.60 B, it has increased by 3.77% over the last week.
No, EVT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, EVT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EVOTEC SE stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 28, 2024, the company has 5.00 K employees. See our rating of the largest employees — is EVOTEC SE on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EVOTEC SE technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EVOTEC SE stock shows the sell signal. See more of EVOTEC SE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on EVOTEC SE future price: according to them, EVT price has a max estimate of 34.83 CHF and a min estimate of 10.19 CHF. Read a more detailed EVOTEC SE forecast: see what analysts think of EVOTEC SE and suggest that you do with its stocks.